Dimensional Fund Advisors LP Cabaletta Bio, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$7.22 - $18.82 $56,741 - $147,906	-7,859 Reduced 30.97%	17,516 $131,000
Q4 2023 Feb 07, 2024	SELL	$12.21 - $23.36 $651,159 - $1.25 Million	-53,330 Reduced 67.76%	25,375 $576,000
Q3 2023 Nov 09, 2023	SELL	$11.84 - $18.65 $663,655 - $1.05 Million	-56,052 Reduced 41.59%	78,705 $1.2 Million
Q1 2023 May 12, 2023	BUY	$7.08 - $12.62 $65,482 - $116,722	9,249 Added 7.37%	134,757 $1.11 Million
Q4 2022 Feb 09, 2023	BUY	$0.64 - $9.3 $80,325 - $1.17 Million	125,508 New	125,508 $1.16 Million
Q1 2022 May 13, 2022	SELL	$1.68 - $3.92 $33,732 - $78,709	-20,079 Reduced 50.27%	19,863 $40,000
Q4 2021 Feb 09, 2022	BUY	$3.36 - $14.64 $134,205 - $584,750	39,942 New	39,942 $151,000

127

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $79.5M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.